SH3 Domains from a Subset of BAR Proteins Define a Ubl-Binding Domain and Implicate Parkin in Synaptic Ubiquitination

Molecular Cell

Volumn 36, Issue 6, 2009, Pages 1034-1047

  Trempe, Jean François ^a   Chen, Carol X Q ^b   Grenier, Karl ^b   Camacho, Edna Matta ^a   Kozlov, Guennadi ^a   McPherson, Peter S ^b   Gehring, Kalle ^a   Fon, Edward A ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

HUMDISEASE; PROTEINS

Indexed keywords

ENDOPHILIN; ENDOPHILIN A; GLUTAMIC ACID; PARKIN; PROTEIN SH3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NERVE ENDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; UBIQUITINATION;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; GLUTAMIC ACID; HUMANS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SRC HOMOLOGY DOMAINS; SYNAPSES; SYNAPTIC TRANSMISSION; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 72149095496     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2009.11.021     Document Type: Article

References (56)

1. Anggono V., Smillie K.J., Graham M.E., Valova V.A., Cousin M.A., and Robinson P.J. Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Nat. Neurosci. 9 (2006) 752-760
2. Avraham E., Rott R., Liani E., Szargel R., and Engelender S. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J. Biol. Chem. 282 (2007) 12842-12850
3. Beasley S.A., Hristova V.A., and Shaw G.S. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease. Proc. Natl. Acad. Sci. USA 104 (2007) 3095-3100
4. Bezsonova I., Bruce M.C., Wiesner S., Lin H., Rotin D., and Forman-Kay J.D. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination. Biochemistry 47 (2008) 8937-8949
5. Chen H., Polo S., Di Fiore P.P., and De Camilli P.V. Rapid Ca2+-dependent decrease of protein ubiquitination at synapses. Proc. Natl. Acad. Sci. USA 100 (2003) 14908-14913
6. Chou J.J., Gaemers S., Howder B., Louis J.M., and Bax A. A simple apparatus for generating stretched polyacrylamide gels, yielding uniform alignment of proteins and detergent micelles. J. Biomol. NMR 21 (2001) 377-382
7. Cousin M.A., Tan T.C., and Robinson P.J. Protein phosphorylation is required for endocytosis in nerve terminals: potential role for the dephosphins dynamin I and synaptojanin, but not AP180 or amphiphysin. J. Neurochem. 76 (2001) 105-116
8. Dawson J.C., Legg J.A., and Machesky L.M. Bar domain proteins: a role in tubulation, scission and actin assembly in clathrin-mediated endocytosis. Trends Cell Biol. 16 (2006) 493-498
9. de Heuvel E., Bell A.W., Ramjaun A.R., Wong K., Sossin W.S., and McPherson P.S. Identification of the major synaptojanin-binding proteins in brain. J. Biol. Chem. 272 (1997) 8710-8716
10. Dominguez C., Boelens R., and Bonvin A.M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (2003) 1731-1737
11. Dunkley P.R., Jarvie P.E., Heath J.W., Kidd G.J., and Rostas J.A. A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res. 372 (1986) 115-129
12. Fallon L., Moreau F., Croft B.G., Labib N., Gu W.J., and Fon E.A. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277 (2002) 486-491
13. Fallon L., Bélanger C.M., Corera A.T., Kontogiannea M., Regan-Klapisz E., Moreau F., Voortman J., Haber M., Rouleau G., Thorarinsdottir T., et al. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat. Cell Biol. 8 (2006) 834-842
14. Gad H., Ringstad N., Löw P., Kjaerulff O., Gustafsson J., Wenk M., Di Paolo G., Nemoto Y., Crun J., Ellisman M.H., et al. Fission and uncoating of synaptic clathrin-coated vesicles are perturbed by disruption of interactions with the SH3 domain of endophilin. Neuron 27 (2000) 301-312
15. Gallop J.L., Jao C.C., Kent H.M., Butler P.J., Evans P.R., Langen R., and McMahon H.T. Mechanism of endophilin N-BAR domain-mediated membrane curvature. EMBO J. 25 (2006) 2898-2910
16. Halbach A., Mörgelin M., Baumgarten M., Milbrandt M., Paulsson M., and Plomann M. PACSIN 1 forms tetramers via its N-terminal F-BAR domain. FEBS J. 274 (2007) 773-782
17. Hampe C., Ardila-Osorio H., Fournier M., Brice A., and Corti O. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. Hum. Mol. Genet. 15 (2006) 2059-2075
18. He Y., Hicke L., and Radhakrishnan I. Structural basis for ubiquitin recognition by SH3 domains. J. Mol. Biol. 373 (2007) 190-196
19. Hedrich K., Eskelson C., Wilmot B., Marder K., Harris J., Garrels J., Meija-Santana H., Vieregge P., Jacobs H., Bressman S.B., et al. Distribution, type, and origin of Parkin mutations: review and case studies. Mov. Disord. 19 (2004) 1146-1157
20. Hicke L., Schubert H.L., and Hill C.P. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 6 (2005) 610-621
21. Hristova V.A., Beasley S.A., Rylett R.J., and Shaw G.S. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J. Biol. Chem. 284 (2009) 14978-14986
22. Huttner W.B., Schiebler W., Greengard P., and De Camilli P. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J. Cell Biol. 96 (1983) 1374-1388
23. Huynh D.P., Scoles D.R., Nguyen D., and Pulst S.M. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12 (2003) 2587-2597
24. Huynh D.P., Nguyen D.T., Pulst-Korenberg J.B., Brice A., and Pulst S.M. Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death. Exp. Neurol. 203 (2007) 531-541
25. Kaneko T., Li L., and Li S.S. The SH3 domain-a family of versatile peptide- and protein-recognition module. Front. Biosci. 13 (2008) 4938-4952
26. Kang J., Kang S., Kwon H.N., He W., and Park S. Distinct interactions between ubiquitin and the SH3 domains involved in immune signaling. Biochim. Biophys. Acta 1784 (2008) 1335-1341
27. Karbowski M., Jeong S.Y., and Youle R.J. Endophilin B1 is required for the maintenance of mitochondrial morphology. J. Cell Biol. 166 (2004) 1027-1039
28. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
29. Kitada T., Pisani A., Karouani M., Haburcak M., Martella G., Tscherter A., Platania P., Wu B., Pothos E.N., and Shen J. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice. J. Neurochem. 110 (2009) 613-621
30. Ko H.S., von Coelln R., Sriram S.R., Kim S.W., Chung K.K., Pletnikova O., Troncoso J., Johnson B., Saffary R., Goh E.L., et al. Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death. J. Neurosci. 25 (2005) 7968-7978
31. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N. Engl. J. Med. 339 (1998) 1044-1053
32. Lee S.Y., Wenk M.R., Kim Y., Nairn A.C., and De Camilli P. Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl. Acad. Sci. USA 101 (2004) 546-551
33. Lücking C.B., Dürr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B.S., Meco G., Denèfle P., Wood N.W., et al., French Parkinson's Disease Genetics Study Group, European Consortium on Genetic Susceptibility in Parkinson's Disease. Association between early-onset Parkinson's disease and mutations in the parkin gene. N. Engl. J. Med. 342 (2000) 1560-1567
34. Masuda M., Takeda S., Sone M., Ohki T., Mori H., Kamioka Y., and Mochizuki N. Endophilin BAR domain drives membrane curvature by two newly identified structure-based mechanisms. EMBO J. 25 (2006) 2889-2897
35. McPherson P.S., Takei K., Schmid S.L., and De Camilli P. p145, a major Grb2-binding protein in brain, is co-localized with dynamin in nerve terminals where it undergoes activity-dependent dephosphorylation. J. Biol. Chem. 269 (1994) 30132-30139
36. McPherson P.S., Garcia E.P., Slepnev V.I., David C., Zhang X., Grabs D., Sossin W.S., Bauerfeind R., Nemoto Y., and De Camilli P. A presynaptic inositol-5-phosphatase. Nature 379 (1996) 353-357
37. Nakamura K., and Edwards R.H. Physiology versus pathology in Parkinson's disease. Proc. Natl. Acad. Sci. USA 104 (2007) 11867-11868
38. Nonis D., Schmidt M.H., van de Loo S., Eich F., Dikic I., Nowock J., and Auburger G. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking. Cell. Signal. 20 (2008) 1725-1739
39. Peter B.J., Kent H.M., Mills I.G., Vallis Y., Butler P.J., Evans P.R., and McMahon H.T. BAR domains as sensors of membrane curvature: the amphiphysin BAR structure. Science 303 (2004) 495-499
40. Qualmann B., and Kelly R.B. Syndapin isoforms participate in receptor-mediated endocytosis and actin organization. J. Cell Biol. 148 (2000) 1047-1062
41. Ringstad N., Nemoto Y., and De Camilli P. The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc. Natl. Acad. Sci. USA 94 (1997) 8569-8574
42. Rubio de la Torre E., Luzón-Toro B., Forte-Lago I., Minguez-Castellanos A., Ferrer I., and Hilfiker S. Combined kinase inhibition modulates parkin inactivation. Hum. Mol. Genet. 18 (2009) 809-823
43. Safadi S.S., and Shaw G.S. A disease state mutation unfolds the parkin ubiquitin-like domain. Biochemistry 46 (2007) 14162-14169
44. Sakata E., Yamaguchi Y., Kurimoto E., Kikuchi J., Yokoyama S., Yamada S., Kawahara H., Yokosawa H., Hattori N., Mizuno Y., et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4 (2003) 301-306
45. Schuske K.R., Richmond J.E., Matthies D.S., Davis W.S., Runz S., Rube D.A., van der Bliek A.M., and Jorgensen E.M. Endophilin is required for synaptic vesicle endocytosis by localizing synaptojanin. Neuron 40 (2003) 749-762
46. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., and Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25 (2000) 302-305
47. Simpson F., Hussain N.K., Qualmann B., Kelly R.B., Kay B.K., McPherson P.S., and Schmid S.L. SH3-domain-containing proteins function at distinct steps in clathrin-coated vesicle formation. Nat. Cell Biol. 1 (1999) 119-124
48. Slepnev V.I., Ochoa G.C., Butler M.H., Grabs D., and De Camilli P. Role of phosphorylation in regulation of the assembly of endocytic coat complexes. Science 281 (1998) 821-824
49. Stamenova S.D., French M.E., He Y., Francis S.A., Kramer Z.B., and Hicke L. Ubiquitin binds to and regulates a subset of SH3 domains. Mol. Cell 25 (2007) 273-284
50. Tan T.C., Valova V.A., Malladi C.S., Graham M.E., Berven L.A., Jupp O.J., Hansra G., McClure S.J., Sarcevic B., Boadle R.A., et al. Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell Biol. 5 (2003) 701-710
51. Tomoo K., Mukai Y., In Y., Miyagawa H., Kitamura K., Yamano A., Shindo H., and Ishida T. Crystal structure and molecular dynamics simulation of ubiquitin-like domain of murine parkin. Biochim. Biophys. Acta 1784 (2008) 1059-1067
52. Tong Y., Pisani A., Martella G., Karouani M., Yamaguchi H., Pothos E.N., and Shen J. R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. USA 106 (2009) 14622-14627
53. Verstreken P., Koh T.W., Schulze K.L., Zhai R.G., Hiesinger P.R., Zhou Y., Mehta S.Q., Cao Y., Roos J., and Bellen H.J. Synaptojanin is recruited by endophilin to promote synaptic vesicle uncoating. Neuron 40 (2003) 733-748
54. Wittekind M., Mapelli C., Lee V., Goldfarb V., Friedrichs M.S., Meyers C.A., and Mueller L. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts. J. Mol. Biol. 267 (1997) 933-952
55. Yamamoto A., Friedlein A., Imai Y., Takahashi R., Kahle P.J., and Haass C. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J. Biol. Chem. 280 (2005) 3390-3399
56. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., and Dawson T.M. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 97 (2000) 13354-13359